K Moeremans
Impact in
-
- Neonatal Health and Biochemistry
-
- Methemoglobinemia and Tumor Lysis Syndrome
Papers in
-
- Antifungal resistance and susceptibility 3
- HIV/AIDS drug development and treatment 3
- Oncology 8
- Neutropenia and Cancer Infections 4
- Co-authors
- Lieven Annemans (20 shared papers)A Uyttebroeck (2 shared papers)R. Pieters (2 shared papers)Han Myint (2 shared papers)Mark Lamotte (2 shared papers)Henk van den Berg (1 shared paper)Erik Smets (5 shared papers)V. Cocquyt (2 shared papers)
- Journals
- Value in Health (20 papers)PharmacoEconomics (2 papers)Critical Reviews in Oncology/Hematology (1 paper)Blood (1 paper)International Journal of Gynecological Cancer (1 paper)
- Partner nations
- BelgiumUnited KingdomSpain
In The Last Decade
K Moeremans
32 papers receiving 389 citations
Peers
Comparison fields: 5 of 55
- Pediatrics, Perinatology and Child Health 117
- Pulmonary and Respiratory Medicine 168
- Hematology 39
- Biochemistry 21
- Infectious Diseases 45
Countries citing papers authored by K Moeremans
This map shows the geographic impact of K Moeremans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Moeremans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Moeremans more than expected).
Fields of papers citing papers by K Moeremans
This network shows the impact of papers produced by K Moeremans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Moeremans. The network helps show where K Moeremans may publish in the future.
Co-authors
The 25 scholars most cited alongside K Moeremans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 117 | |
| 2 | 2003 | 57 | |
| 3 | 2006 | 27 | |
| 4 | 2006 | 26 | |
| 5 | 2003 | 21 | |
| 6 | 2006 | 20 | |
| 7 | 2000 | 19 | |
| 8 | 2006 | 19 | |
| 9 | 2010 | 18 | |
| 10 | 2010 | 14 | |
| 11 | 2006 | 11 | |
| 12 | 2018 | 9 | |
| 13 | 2004 | 9 | |
| 14 | 2002 | 8 | |
| 15 | 2004 | 6 | |
| 16 | 2006 | 5 | |
| 17 | Economic impact of hospital malnutrition | 2005 | 4 |
| 18 | 2003 | 4 | |
| 19 | 2005 | 3 | |
| 20 | 2002 | 2 |
About K Moeremans
K Moeremans is a scholar working on Infectious Diseases, Oncology, Pulmonary and Respiratory Medicine, Epidemiology and Economics and Econometrics, having authored 36 papers that have together received 413 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Neutropenia and Cancer Infections (4 papers), Antifungal resistance and susceptibility (3 papers), HIV/AIDS drug development and treatment (3 papers), Hepatitis C virus research (3 papers), Methemoglobinemia and Tumor Lysis Syndrome (3 papers), Bacterial Infections and Vaccines (2 papers) and Fungal Infections and Studies (2 papers). The work is most often cited by research in Pediatrics, Perinatology and Child Health (117 citations), Pulmonary and Respiratory Medicine (168 citations), Hematology (39 citations), Biochemistry (21 citations) and Infectious Diseases (45 citations). K Moeremans has collaborated with scholars based in Belgium, United Kingdom and Spain. Frequent co-authors include Lieven Annemans, A Uyttebroeck, R. Pieters, Han Myint, Mark Lamotte, Henk van den Berg, Henk van den Berg, Erik Smets, V. Cocquyt and Simon Van Belle. Their work appears in journals such as Value in Health, PharmacoEconomics, Critical Reviews in Oncology/Hematology, Blood and International Journal of Gynecological Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.